ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
사르탄 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 221억 8,000만 달러에서 2026년에는 230억 9,000만 달러에 이르고, CAGR 4.1%의 성장이 전망됩니다. 지난 몇 년간의 성장 요인으로는 전 세계 고혈압 환자의 높은 비율, 심혈관 질환의 부담, 제네릭 의약품의 보급, 병원 처방, 살탄의 장기적인 안전성 프로파일 등이 꼽힙니다.
사르탄계 약제 시장 규모는 향후 몇 년간, 꾸준한 성장이 전망됩니다. 2030년에는 271억 4,000만 달러에 이르고, CAGR은 4.1%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 고령화 사회의 진전, 신장 질환 발생률 증가, 비용 효율적인 치료법에 대한 수요, 외래 치료의 확대, 디지털 약국의 성장 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 고혈압 관리에서의 사용 증가, 제네릭 혈관 긴장 인자 수용체 길항제의 성장, 복합 심혈관 치료 선호, 온라인 약국 유통 확대, 신장 및 심혈관 보호에 대한 관심 증가 등이 있습니다.
고혈압 유병률 증가는 향후 몇 년 동안 살탄계 약물 시장의 성장을 견인할 것으로 예측됩니다. 고혈압은 지속적인 고혈압을 특징으로 하는 질환으로 심장병, 뇌졸중 및 기타 심각한 건강 합병증의 위험을 증가시킵니다. 이 질환의 발병률 증가는 주로 소금과 가공식품이 많은 식습관과 관련이 있으며, 이는 체액 저류를 유발하여 심장에 더 많은 부담을 줍니다. 살탄계 약물은 혈관을 수축시키는 호르몬인 안지오텐신 II를 억제하여 고혈압을 관리합니다. 이 작용은 혈관을 이완 및 확장시켜 혈압을 낮추고 심장의 부담을 줄여줍니다. 예를 들어, 2025년 9월 스위스에 본부를 둔 국제 공중보건기구인 세계보건기구(WHO)는 2024년 기준 전 세계 30-79세 성인 중 약 14억 명이 고혈압을 앓고 있으며, 이는 전 세계 인구의 약 33%에 해당한다고 보고한 바 있습니다. 따라서 고혈압 유병률 증가는 사르탄계 약물 시장을 견인하고 있습니다.
살탄 시장에서 사업을 전개하는 주요 기업들은 치료 효과와 환자의 복약 순응도를 높이기 위해 정제형 살탄 등 첨단 제품 개발에 주력하고 있습니다. 정제 형태의 살탄은 경구용 약물로 안지오텐신 II의 작용을 억제하여 혈관 이완을 촉진하고 혈압을 낮추는 역할을 합니다. 예를 들어, 2024년 7월 인도에 본사를 둔 제약회사 자이더스 라이프사이언시스(Zaidas Life Sciences)는 '디오반(Diovan)'이라는 브랜드로 판매되는 발사르탄 정제 USP(40mg, 80mg)에 대해 미국 FDA의 승인을 획득했습니다. 이 정제는 성인의 고혈압, 심부전, 심근경색 후 생존율 향상을 목적으로 처방되며, 1세 이상의 소아 환자에게도 사용하도록 승인되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Sartans, also known as angiotensin II receptor blockers (ARBs), are medications commonly used to treat high blood pressure (hypertension) and heart failure. They work by blocking the effects of angiotensin II, a hormone that constricts blood vessels, thereby promoting vessel relaxation, lowering blood pressure, and improving circulation. Sartans also help reduce the risk of strokes, kidney damage, and heart attacks in patients with certain cardiovascular conditions.
The main types of sartans include valsartan, telmisartan, losartan, irbesartan, azilsartan, and olmesartan. Valsartan is an angiotensin II receptor blocker that lowers blood pressure and decreases cardiac strain by relaxing blood vessels. These medications are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, and are used for applications such as hypertension, cardiovascular diseases, kidney diseases, and more. End users include hospitals, diagnostic laboratories, and other healthcare facilities.
Tariffs have impacted the sartans market by increasing the cost of imported APIs and pharmaceutical intermediates used in antihypertensive drug manufacturing. These impacts are most pronounced in generic drug manufacturing hubs across Asia Pacific and Europe, where large scale production relies on cross border sourcing. Rising tariff related expenses have pressured pricing structures and procurement margins for manufacturers and distributors. This has influenced sourcing strategies and competitive dynamics in both domestic and export markets. However, tariffs have encouraged domestic API production, localized sourcing initiatives, and strengthened long term supply chain resilience.
The sartans market research report is one of a series of new reports from The Business Research Company that provides sartans market statistics, including sartans industry global market size, regional shares, competitors with a sartans market share, detailed sartans market segments, market trends and opportunities, and any further data you may need to thrive in the sartans industry. This sartans market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sartans market size has grown steadily in recent years. It will grow from $22.18 billion in 2025 to $23.09 billion in 2026 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to high global hypertension prevalence, cardiovascular disease burden, generic drug adoption, hospital-based prescribing, long-term safety profile of sartans.
The sartans market size is expected to see steady growth in the next few years. It will grow to $27.14 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to aging population, rising kidney disease incidence, demand for cost-effective therapies, outpatient treatment expansion, growth of digital pharmacies. Major trends in the forecast period include increasing use in hypertension management, growth of generic angiotensin receptor blockers, preference for combination cardiovascular therapy, expansion of online pharmacy distribution, focus on renal and cardiovascular protection.
The rising prevalence of hypertension is expected to drive the growth of the sartans market in the coming years. Hypertension is a condition characterized by persistently high blood pressure, increasing the risk of heart disease, stroke, and other serious health complications. Its growing incidence is largely associated with diets high in salt and processed foods, which cause fluid retention and place additional strain on the heart. Sartans manage hypertension by blocking angiotensin II, a hormone that constricts blood vessels. This action relaxes and widens the vessels, lowers blood pressure, and reduces the heart's workload. For example, in September 2025, the World Health Organization, a Switzerland-based international public health agency, reported that approximately 1.4 billion adults aged 30-79 worldwide were living with hypertension in 2024, representing about 33% of the global population. Therefore, the rising prevalence of hypertension is boosting the sartans market.
Major companies operating in the sartans market are focusing on developing advanced products, such as tablet-form sartans, to improve treatment effectiveness and patient adherence. Tablet-form sartans are oral medications that block the effects of angiotensin II, promoting vessel relaxation and reducing blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, received US FDA approval for Valsartan Tablets USP (40 mg, 80 mg), marketed under the brand name Diovan. These tablets are prescribed for hypertension, heart failure, and to improve survival after heart attack in adults, and are also approved for pediatric patients aged one year and older.
In April 2025, Scienture Holdings, Inc., a US-based sartan manufacturer, partnered with Saptalis Pharmaceuticals to produce Arbli (losartan potassium oral suspension, 10 mg/mL). The collaboration includes warehousing and distribution agreements with strategic partners to ensure market readiness for the first FDA-approved ready-to-use oral liquid losartan, addressing unmet needs in hypertension treatment. Saptalis Pharmaceuticals is a US-based pharmaceutical company.
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.
North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sartans market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sartans market consists of sales of candesartan, eprosartan, and fimasartan. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sartans Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sartans market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sartans ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sartans market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Fintech, Blockchain, Regtech & Digital Finance
4.2. Major Trends
4.2.1 Increasing Use In Hypertension Management
4.2.2 Growth Of Generic Angiotensin Receptor Blockers
4.2.3 Preference For Combination Cardiovascular Therapy
4.2.4 Expansion Of Online Pharmacy Distribution
4.2.5 Focus On Renal And Cardiovascular Protection
5. Sartans Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Cardiology Centers
5.4 Retail Pharmacies
5.5 Online Pharmacies
6. Sartans Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Sartans Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Sartans PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Sartans Market Size, Comparisons And Growth Rate Analysis
7.3. Global Sartans Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Sartans Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Sartans Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Sartans Market Segmentation
9.1. Global Sartans Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.1. Global Sartans Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Sartans Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Sartans Market
11.1. Asia-Pacific Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Sartans Market
12.1. China Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Sartans Market
13.1. India Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Sartans Market
14.1. Japan Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Sartans Market
15.1. Australia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Sartans Market
16.1. Indonesia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Sartans Market
17.1. South Korea Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Sartans Market
18.1. Taiwan Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Sartans Market
19.1. South East Asia Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Sartans Market
20.1. Western Europe Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Sartans Market
21.1. UK Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Sartans Market
22.1. Germany Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Sartans Market
23.1. France Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Sartans Market
24.1. Italy Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Sartans Market
25.1. Spain Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Sartans Market
26.1. Eastern Europe Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Sartans Market
27.1. Russia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Sartans Market
28.1. North America Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Sartans Market
29.1. USA Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Sartans Market
30.1. Canada Sartans Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Sartans Market
31.1. South America Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Sartans Market
32.1. Brazil Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Sartans Market
33.1. Middle East Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Sartans Market
34.1. Africa Sartans Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Sartans Market Regulatory and Investment Landscape
36. Sartans Market Competitive Landscape And Company Profiles
36.1. Sartans Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Sartans Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Sartans Market Company Profiles
36.3.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Sartans Market Other Major And Innovative Companies
